Oxytocin and Alcohol Withdrawal and Dependence

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 22, 2018

Study Completion Date

January 22, 2018

Conditions
AlcoholismSubstance-Related Disorders
Interventions
DRUG

intranasal oxytocin spray

6 insufflations (24 IU of oxytocin total) given twice daily, day 1-3. 2 insufflations (8 IU of oxytocin total) as needed, max thrice daily, day 3-30.

OTHER

intranasal spray without oxytocin

6 insufflations (24 IU of placebo total) given twice daily, day 1-3. 2 insufflations (8 IU of placebo total) as needed, max thrice daily, day 3-30.

Trial Locations (1)

Unknown

Lade Addiction Treatment Center, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

Lade Addiction Treatment Center

UNKNOWN

lead

Norwegian University of Science and Technology

OTHER

NCT02903251 - Oxytocin and Alcohol Withdrawal and Dependence | Biotech Hunter | Biotech Hunter